Home > News > St. Joseph's Among First in U.S. to Use New Technology
January 19th, 2004
St. Joseph's Among First in U.S. to Use New Technology
Researchers at St. Joseph's Hospital and Medical Center are among the first in the country to use a new molecular diagnostic tool to help develop genetic tests for Alzheimer's disease. St. Joseph's DNA Diagnostic Laboratories validated the test in collaboration with Nanogen, Inc., a company that develops and commercializes molecular diagnostic products for the gene-based testing market.
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014
ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014
An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014